|
KIAA1109 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.33781874467331E-13 |
| Normal-vs-Stage2 |
4.93030000003891E-06 |
| Normal-vs-Stage3 |
3.5527136788005E-15 |
| Normal-vs-Stage4 |
2.35855779351368E-12 |
| Stage1-vs-Stage2 |
3.267600E-01 |
| Stage1-vs-Stage3 |
3.647800E-02 |
| Stage1-vs-Stage4 |
3.106300E-02 |
| Stage2-vs-Stage3 |
2.207700E-02 |
| Stage2-vs-Stage4 |
1.598270E-02 |
| Stage3-vs-Stage4 |
5.762200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.83100000000259E-05 |
| Normal-vs-Asian |
2.12220000461727E-08 |
| Caucasian-vs-AfricanAmerican |
1.953370E-01 |
| Caucasian-vs-Asian |
4.093400E-01 |
| AfricanAmerican-vs-Asian |
5.646200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.62643290133747E-14 |
| Normal-vs-Female |
1.62625468647093E-12 |
| Male-vs-Female |
5.472000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.52766729558607E-12 |
| Normal-vs-Age(41-60Yrs) |
5.20694598549198E-14 |
| Normal-vs-Age(61-80Yrs) |
1.93367544198964E-12 |
| Normal-vs-Age(81-100Yrs) |
5.154700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.680600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.950000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.297400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.889600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.349400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.909600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.387800E-04 |
| Classical-VS-Follicular |
2.254200E-02 |
| Classical-VS-Other |
3.403000E-01 |
| Classical-VS-Normal |
5.83989523406103E-11 |
| Tall-VS-Follicular |
1.64942999999473E-05 |
| Tall-VS-Other |
5.687600E-01 |
| Tall-VS-Normal |
2.38697950294409E-14 |
| Follicular-VS-Other |
2.719700E-02 |
| Follicular-VS-Normal |
2.47959999999381E-05 |
| Other-VS-Normal |
3.385100E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.65136826224943E-12 |
| Normal-vs-N1 |
1.21402887742761E-12 |
| N0-vs-N1 |
4.502500E-02 |
|
|
